LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Novel β-casein derived antioxidant and ACE-inhibitory active peptide from camel milk fermented by Leuconostoc lactis PTCC1899: Identification and molecular docking

Photo by andriklangfield from unsplash

Abstract Antioxidant and angiotensin-I converting enzyme inhibitory (ACE-I) activities of bioactive peptide fractions from camel milk fermented by Leuconostoc lactis PTCC 1899 were assessed. The fraction m TE mg−1 protein)… Click to show full abstract

Abstract Antioxidant and angiotensin-I converting enzyme inhibitory (ACE-I) activities of bioactive peptide fractions from camel milk fermented by Leuconostoc lactis PTCC 1899 were assessed. The fraction m TE mg−1 protein) activities and was purified through RP-HPLC. The active peptide, MVPYPQR, with antioxidant (8933.05 μ m TE mg−1 peptide) and ACE-I (IC50 = 30 μ m ) activities was identified. To investigate the ACE-I mechanism of the purified peptide the docking study was performed. The presence of hydrogen bond between Gln 162 (S'1 pocket of ACE) and Arg in the C terminal of the peptide was identified and the peptide could distort the Zn2+ tetrahedral geometry of the enzyme. This study showed the ability of Leuc. lactis to produce a novel and safe functional food by hydrolysing the milk proteins during the fermentation.

Keywords: camel milk; milk fermented; ace; peptide; lactis

Journal Title: International Dairy Journal
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.